A new study presents robust evidence on the role of lysophosphatidylcholines (LPCs) in the onset of Alzheimer’s disease. Researchers discovered that LPCs—compounds that transport a variety of healthy fatty acids to the brain—either promote Alzheimer’s or protect against it, depending on a person’s genetics.
This article was originally published on MedicalXpress.com

